Interestingly, recent studies reported that AR is expressed in 70–90% of all breast cancers [12–15] and 22–35% of TNBC [16, 17], suggesting that AR could be a potential therapeutic target for treating breast cancer [18, 19]. The gene discussed is AR; the disease is breast cancer.